KEAP1 and done? Targeting the NRF2 pathway with sulforaphane: Targeting the NRF2 Pathway with Sulforaphane

Albena T. Dinkova-Kostova, Jed W. Fahey, Rumen V. Kostov, Thomas W. Kensler (Lead / Corresponding author)

    Research output: Contribution to journalReview articlepeer-review

    197 Citations (Scopus)
    625 Downloads (Pure)


    Background: Since the re-discovery of sulforaphane in 1992 and the recognition of the bioactivity of this phytochemical, many studies have examined its mode of action in cells, animals and humans. Broccoli, especially as young sprouts, is a rich source of sulforaphane and broccoli-based preparations are now used in clinical studies probing efficacy in health preservation and disease mitigation. Many putative cellular targets are affected by sulforaphane although only one, KEAP1-NRF2 signaling, can be considered a validated target at this time. The transcription factor NRF2 is a master regulator of cell survival responses to endogenous and exogenous stressors.

    Scope and Approach: This review summarizes the chemical biology of sulforaphane as an inducer of NRF2 signaling and efficacy as an inhibitor of carcinogenesis. It also provides a summary of the current findings from clinical trials using a suite of broccoli sprout preparations on a series of short-term endpoints reflecting a diversity of molecular actions.

    Key Findings and Conclusions: Sulforaphane, as a pure chemical, protects against chemical-induced skin, oral, stomach, colon, lung and bladder carcinogenesis and in genetic models of colon and prostate carcinogenesis. In many of these settings the antitumorigenic efficacy of sulforaphane is dampened in Nrf2-disrupted animals. Broccoli preparations rich in glucoraphanin or sulforaphane exert demonstrable pharmacodynamic action in over a score of clinical trials. Measures of NRF2 pathway response and function are serving as guideposts for the optimization of dose, schedule and formulation as clinical trials with broccoli-based preparations become more commonplace and more rigorous in design and implementation.

    Original languageEnglish
    Pages (from-to)257-269
    Number of pages13
    JournalTrends in Food Science and Technology
    Issue numberB
    Early online date16 Feb 2017
    Publication statusPublished - Nov 2017


    • Clinical trial
    • Cytoprotection
    • KEAP1
    • NRF2
    • Sulforaphane

    ASJC Scopus subject areas

    • Biotechnology
    • Food Science


    Dive into the research topics of 'KEAP1 and done? Targeting the NRF2 pathway with sulforaphane: Targeting the NRF2 Pathway with Sulforaphane'. Together they form a unique fingerprint.

    Cite this